Skip to main content

Table 3 Baseline and late IPSS, ICIQ and IPSS-QoL assessment

From: Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy

Variable

Baseline

Last Follow-up

 
 

n (%)

mean (sd)

n (%)

mean (sd)

p-value#

IPSS:

 IPSS value

69 (100%)

7.7 (6.2)

68 (98.6%)

7.5 (5.6)

1.000

 missing

0

 

1 (1.4%)

  

IPSS grouped:

 Mild (0–7)

40 (58.0%)

 

38 (55.1%)

  

 Moderate (8–19)

25 (36.2%)

 

28 (40.6%)

  

 Severe (20–35)

4 (5.8%)

 

2 (2.9%)

  

ICIQ:

 ICIQ value:

64 (92.8%)

5.8 (4.7)

68 (98.6%)

5.6 (4.2)

0.874

 missing

5 (7.2%)

 

1 (1.4%)

  

ICIQ grouped:

 No incontinence (0)

15 (21.7%)

 

15 (21.7%)

  

 Mild incontinence (1–5)

18 (26.1%)

 

20 (29.0%)

  

 Moderate incontinence (6–10)

21 (30.4%)

 

24 (34.8%)

  

 Severe incontinence (≥11)

10 (14.5%)

 

9 (13.0%)

  

IPSS-QoL score grouped:a

 Satisfied (0–2)

47 (68.1%)

 

49 (71.0%)

  

 dissatisfied (3–6)

18 (26.1%)

 

19 (27.6%)

  

 missing

4 (5.8%)

 

1 (1.4%)

  
  1. Abbrevations: sd standard deviation, IPSS International Prostate Symptom Score, ICIQ International Consultation on Incontinence questionnaire, QoL quality of life
  2. #by paired t-Test
  3. aIPSS-QoL-Score: 0 = delighted to 6 = terrible